top of page
Ozempic 0.5mg 香港正貨 (包括注射前基本身體檢查)

Ozempic® 0.5 mg Injection Pen — Basic Pre-injection Health Check Included

What is Ozempic®?

Ozempic® is a prescription medicine developed by the Danish pharmaceutical company Novo Nordisk. Its active ingredient is semaglutide, which belongs to a class of medicines known as GLP-1 receptor agonists.

Ozempic® may help improve insulin secretion, support more stable blood glucose control and assist with metabolic health management under medical supervision.

Ozempic® is supplied as a pre-filled injection pen and is usually administered once weekly. Since 2017, Ozempic® has been approved by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA), and is used in many regions worldwide, including Hong Kong.

A basic pre-injection health check is required before starting the programme. This includes:

  • Liver function test
  • Kidney function test
  • Fasting blood glucose
  • HbA1c
  • Urinalysis
  • Basic physical examination

This programme must be used under the guidance of qualified healthcare professionals and prescribed by a doctor.

If required, a nurse may assist with the first injection.

A one-to-one registered dietitian consultation service is also available to support your weight management plan.*

  • Ozempic® may be considered for adults who:

    • Have a BMI of 30 kg/m² or above
    • Have a BMI of 27 kg/m² to below 30 kg/m², with relevant metabolic or health concerns
    • Have a busy urban lifestyle and find it difficult to maintain regular exercise
    • Frequently experience a large appetite, snack cravings or late-night eating habits

    Suitability must be assessed by a doctor based on your medical history, current health condition and treatment needs.

HK$3,900.00Price
Quantity

Related Products

bottom of page